Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CATM
2026
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $2.27M | ﹤0.01% |
67,400
-37,944
| -36% | -$1.32M |
|
|
FNFV
2027
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $2.26M | ﹤0.01% |
201,000
-39,555
| -16% | -$439K |
|
2028
Embotelladora Andina Series A
AKO.A
$3.76B
| $2.26M | ﹤0.01% |
138,600
+600
| +0.4% | +$10.1K |
|
2029
First Bancorp
FNLC
$402M
| $2.26M | ﹤0.01% |
110,200
+15,706
| +17% | +$327K |
|
|
SGYP
2030
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $2.25M | ﹤0.01% |
+397,600
| New | +$2.42M |
|
2031
QCR Holdings
QCRH
$1.73B
| $2.25M | ﹤0.01% |
92,500
-21,012
| -19% | -$489K |
|
2032
Bank of America
BAC
$448B
| $2.25M | ﹤0.01% |
+133,430
| New | +$2.26M |
|
2033
Las Vegas Sands
LVS
$29.6B
| $2.25M | ﹤0.01% |
+51,200
| New | +$2.33M |
|
|
EXK
2034
Endeavour Silver
EXK
$3.05B
| $2.24M | ﹤0.01% |
1,578,900
+509,900
| +48% | +$791K |
|
|
KAMN
2035
DELISTED
Kaman Corp
KAMN
| $2.24M | ﹤0.01% |
54,900
-50,022
| -48% | -$1.96M |
|
|
TCP
2036
DELISTED
TC Pipelines LP
TCP
| $2.23M | ﹤0.01% |
44,900
-13,032
| -22% | -$645K |
|
2037
Standard BioTools
LAB
$312M
| $2.22M | ﹤0.01% |
205,000
+43,488
| +27% | +$427K |
|
|
GTT
2038
DELISTED
GTT Communications, Inc.
GTT
| $2.21M | ﹤0.01% |
129,700
+78,400
| +153% | +$1.56M |
|
2039
Orrstown Financial Services
ORRF
$850M
| $2.2M | ﹤0.01% |
123,500
+9,300
| +8% | +$164K |
|
2040
Travelzoo
TZOO
$75.5M
| $2.2M | ﹤0.01% |
263,200
+42,200
| +19% | +$371K |
|
2041
American Financial Group
AFG
$12B
| $2.2M | ﹤0.01% |
30,500
+9,200
| +43% | +$663K |
|
|
PCOM
2042
DELISTED
Points.com Inc. Common Shares
PCOM
| $2.19M | ﹤0.01% |
228,900
+22,400
| +11% | +$225K |
|
|
N
2043
DELISTED
Netsuite Inc
N
| $2.19M | ﹤0.01% |
+25,900
| New | +$2.22M |
|
|
CSCI
2044
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $2.19M | ﹤0.01% |
4,878
+3,750
| +332% | +$2.35M |
|
2045
Graham Corp
GHM
$1.33B
| $2.18M | ﹤0.01% |
129,800
+21,400
| +20% | +$375K |
|
2046
CenterPoint Energy
CNP
$26.7B
| $2.18M | ﹤0.01% |
118,800
-1,226,042
| -91% | -$21.8M |
|
|
SHOS
2047
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $2.18M | ﹤0.01% |
272,500
+133,002
| +95% | +$1.09M |
|
|
ICAD
2048
DELISTED
iCAD Inc
ICAD
| $2.18M | ﹤0.01% |
421,099
+67,239
| +19% | +$267K |
|
2049
Icahn Enterprises
IEP
$5.33B
| $2.18M | ﹤0.01% |
+35,497
| New | +$2.57M |
|
2050
Orion Group Holdings
ORN
$402M
| $2.17M | ﹤0.01% |
520,900
+147,700
| +40% | +$641K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.